Abstract |
Total sleep deprivation (SD) has been found to mitigate motor dysfunctions in Parkinson's disease. Apparently, the similar sensitivity of an animal model for parkinsonism would support the model's validity. Recently, we described catalepsy induced in Wistar rats by somatostatin antagonist, cyclosomatostatin (cSST); this model simulates such a disease-associated abnormality as a fall in brain somatostatin levels. To evaluate the similarity between the cSST model and Parkinson's disease, we assessed here the responsiveness of cSST-induced catalepsy to 1-h and 3-h SD. In parallel, the influence of SD on catalepsy induced by a dopamine receptor antagonist, haloperidol, was examined. It was found that the short-term SD failed to influence cataleptic responses of both types (sleep deprived rats and undisturbed ones displayed a similar duration of immobility, p > 0.05). By contrast, 3-h SD suppressed (p < 0.01) cSST-induced catalepsy, however, enhanced (p < 0.01) cataleptic response to haloperidol. Thus, the anti-cataleptic effect of SD appears to be cSST-specific. These findings support the validity of the cSST-induced catalepsy in Wistar rats as a model for parkinsonian motor dysfunctions.
|
Authors | Ilya D Ionov, Irina I Pushinskaya, Nicholas P Gorev, David D Frenkel |
Journal | Neuroscience letters
(Neurosci Lett)
Vol. 684
Pg. 72-77
(09 25 2018)
ISSN: 1872-7972 [Electronic] Ireland |
PMID | 29990558
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018 Elsevier B.V. All rights reserved. |
Chemical References |
- Antipsychotic Agents
- Dopamine Antagonists
- Peptides, Cyclic
- cyclosomatostatin
- Haloperidol
|
Topics |
- Animals
- Antipsychotic Agents
(toxicity)
- Catalepsy
(chemically induced, physiopathology, therapy)
- Dopamine Antagonists
(toxicity)
- Haloperidol
(toxicity)
- Immobilization
(methods)
- Injections, Intraventricular
- Male
- Peptides, Cyclic
(toxicity)
- Rats
- Rats, Wistar
- Sleep Deprivation
(physiopathology)
|